4.8 Article

Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-11745-1

关键词

-

资金

  1. AMED-CREST [JP18gm1110004]
  2. AMED P -CREATE [JP18cm0106203]
  3. JSPS KAKENHI [18H04026]
  4. Research Grants of Princess Takamatsu Cancer Research Fund
  5. Takeda Science Foundation
  6. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  7. Naito Foundation
  8. World Premier International Research Center Initiative (WPI), MEXT, Japan
  9. Grants-in-Aid for Scientific Research [18H04026] Funding Source: KAKEN

向作者/读者索取更多资源

Clear cell sarcoma (CCS) is a rare soft tissue sarcoma caused by the EWS/ATF1 fusion gene. Here, we established induced pluripotent stem cells (iPSCs) from EWS/ATF1-controllable murine CCS cells harboring sarcoma-associated genetic abnormalities. Sarcoma-iPSC mice develop secondary sarcomas immediately after EWS/ATF1 induction, but only in soft tissue. EWS/ATF1 expression induces oncogene-induced senescence in most cell types in sarcoma-iPSC mice but prevents it in sarcoma cells. We identify Tppp3-expressing cells in peripheral nerves as a cell-of-origin for these sarcomas. We show cell type-specific recruitment of EWS/ATF1 to enhancer regions in CCS cells. Finally, epigenetic silencing at these enhancers induces senescence and inhibits CCS cell growth through altered EWS/ATF1 binding. Together, we propose that distinct responses to premature senescence are the basis for the cell type-specificity of cancer development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据